ENTYVIO

takeda canada inc🇨🇦 Health Canada

Approval Id: ad2f103d82a6ea73
Drug Approval Canada Name: ENTYVIO
Product Name: ENTYVIO
Status: Marketed
Status Date: 2020-11-20
Original Market Date: 2020-11-20
Din: 02497875
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Schedule D , Prescription
Ahfs: 90:24.92
Atc Original: L04AG05 VEDOLIZUMAB
Atc Name: l 04 ag 05
Aig Number: 0156530002
Company Name: takeda canada inc
Company Address: 3800, 22 Adelaide Street West, Toronto, Ontario, Canada, M5H 4E3

VEDOLIZUMAB

108 MG / 0.68 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

ad2f103d82a6ea73

Type

Standard